Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quigg

Showing results (571-580 of 581) with videos related to

Pageof 59
Sort By:
Blood|June 7, 2022
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTCGeoffrey D E Cuvelier, Brent R Logan, Susan E Prockop, et al.
Journal of Clinical Immunology|August 4, 2019
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCTRebecca A Marsh, Jennifer W Leiding, Brent R Logan, et al.
Blood|April 9, 2020
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC reportLauri M Burroughs, Aleksandra Petrovic, Ruta Brazauskas, et al.
Journal of Clinical Immunology|August 30, 2020
Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCTRebecca A Marsh, Jennifer W Leiding, Brent R Logan, et al.
Journal of Clinical Immunology|October 2, 2020
Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC CentersMorna J Dorsey, Nicola A M Wright, Natalia S Chaimowitz, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Blood|August 30, 2018
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recoveryElie Haddad, Brent R Logan, Linda M Griffith, et al.
Lancet (London, England)|June 23, 2023
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment ConsortiumMonica S Thakar, Brent R Logan, Jennifer M Puck, et al.
Journal of Human Immunity|July 8, 2026
Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC reportLena E Winestone, Brent R Logan, Xuerong Liu, et al.
JAMA Neurology|March 24, 2020
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical TrialsMerit Cudkowicz, Marianne K Chase, Christopher S Coffey, et al.
Pageof 59

Showing results (571-580 of 581) with videos related to

Sort By:
Pageof 59
Blood|June 7, 2022
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTCGeoffrey D E Cuvelier, Brent R Logan, Susan E Prockop, et al.
Journal of Clinical Immunology|August 4, 2019
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCTRebecca A Marsh, Jennifer W Leiding, Brent R Logan, et al.
Blood|April 9, 2020
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC reportLauri M Burroughs, Aleksandra Petrovic, Ruta Brazauskas, et al.
Journal of Clinical Immunology|August 30, 2020
Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCTRebecca A Marsh, Jennifer W Leiding, Brent R Logan, et al.
Journal of Clinical Immunology|October 2, 2020
Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC CentersMorna J Dorsey, Nicola A M Wright, Natalia S Chaimowitz, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Blood|August 30, 2018
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recoveryElie Haddad, Brent R Logan, Linda M Griffith, et al.
Lancet (London, England)|June 23, 2023
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment ConsortiumMonica S Thakar, Brent R Logan, Jennifer M Puck, et al.
Journal of Human Immunity|July 8, 2026
Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC reportLena E Winestone, Brent R Logan, Xuerong Liu, et al.
JAMA Neurology|March 24, 2020
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical TrialsMerit Cudkowicz, Marianne K Chase, Christopher S Coffey, et al.
Pageof 59